Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Stroke

Multiomic approaches to stroke: the beginning of a journey

Subjects

Using integrative multiomics, a new study has shed light on the aetiology of ischaemic stroke. By probing the mechanisms underlying stroke, such approaches could aid the development of therapies and improve risk prediction and stratification, with the ultimate aim of developing personalized preventive and therapeutic strategies.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Jung, J., Lu, Z., de Smith, A. & Mancuso, N. Novel insight into the etiology of ischemic stroke gained by integrative multiome-wide association study. Hum. Mol. Genet. https://doi.org/10.1093/hmg/ddad174 (2023).

    Article  PubMed  PubMed Central  Google Scholar 

  2. Rusina, P. V. et al. Genetic support for FDA-approved drugs over the past decade. Nat. Rev. Drug Discov. 22, 864 (2023).

    Article  CAS  PubMed  Google Scholar 

  3. Montaner, J. et al. Multilevel omics for the discovery of biomarkers and therapeutic targets for stroke. Nat. Rev. Neurol. 16, 247–264 (2020).

    Article  PubMed  Google Scholar 

  4. Mishra, A. et al. Stroke genetics informs drug discovery and risk prediction across ancestries. Nature 611, 115–123 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Liu, P. Y. et al. TMEM16A inhibition preserves blood-brain barrier integrity after ischemic stroke. Front. Cell. Neurosci. 13, 360 (2019).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Konuma, T., Ogawa, K. & Okada, Y. Integration of genetically regulated gene expression and pharmacological library provides therapeutic drug candidates. Hum. Mol. Genet. 30, 294–304 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Ryu, J. R. et al. Stroke-associated intergenic variants modulate a human FOXF2 transcriptional enhancer. Proc. Natl Acad. Sci. USA 119, e2121333119 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Kichaev, G. et al. Integrating functional data to prioritize causal variants in statistical fine-mapping studies. PLoS Genet. 10, e1004722 (2014).

    Article  PubMed  PubMed Central  Google Scholar 

  9. Weeks, E. M. et al. Leveraging polygenic enrichments of gene features to predict genes underlying complex traits and diseases. Nat. Genet. 55, 1267–1276 (2023).

    Article  CAS  PubMed  Google Scholar 

  10. Wilson, D. M. III et al. Hallmarks of neurodegenerative diseases. Cell 186, 693–714 (2023).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Stéphanie Debette.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Debette, S., Chasman, D.I. Multiomic approaches to stroke: the beginning of a journey. Nat Rev Neurol 20, 65–66 (2024). https://doi.org/10.1038/s41582-023-00908-w

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41582-023-00908-w

Search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research